Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis

Abstract Complex diseases may not always progress in a gradual manner. In the early stages of complex diseases, obvious symptoms are usually not observable, but there is a commonality: there is a brief state of predisease between the progression from normal state to disease state, which usually incl...

Full description

Saved in:
Bibliographic Details
Main Authors: Peiyu Li, Shaowen Jing, Guo Tian, Jing Jiang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87438-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571668554317824
author Peiyu Li
Shaowen Jing
Guo Tian
Jing Jiang
author_facet Peiyu Li
Shaowen Jing
Guo Tian
Jing Jiang
author_sort Peiyu Li
collection DOAJ
description Abstract Complex diseases may not always progress in a gradual manner. In the early stages of complex diseases, obvious symptoms are usually not observable, but there is a commonality: there is a brief state of predisease between the progression from normal state to disease state, which usually includes three stages: normal state, critical state of predisease, and disease state. Identifying this critical state, especially with a single sample from an individual, remains a difficult task. In this study, we applied three methods, i.e., single-sample Jensen–Shannon Divergence (sJSD), network information gain (NIG), and temporal network flow entropy (TNFE) method, to a simulated dataset and type 2 diabetes (GSE13268 and GSE13269). Three different methods were utilized to create indexes, including the Inconsistency Index (ICI), NIG, and TNFE, to measure the overall disruption caused by individual samples compared to a set of reference samples. Changes in these indexes were used to identify critical states during the progression of the disease. Results from the numerical simulations show the effectiveness of the three methods. All the methods can detect two critical states based on a single sample, which are respectively at 8 weeks and 16 weeks for GSE13268 and at 4 weeks and 16 weeks for GSE13269, indicating the critical states before deterioration can be detected and the dynamic network biomarkers (DNBs) can be identified successfully. But there are differences in the sensitivity of predictive indicators based on the three methods. The identified dynamic network biomarkers are also significantly different. In addition, the computational principles of the three methods are compared. The proposed three methods can effectively detect the critical state and identify the DNB, solely based on a single sample. The three methods are data-driven and model-free on an individual basis. sJSD method is more sensitive to the critical state, while NIG and TNFE methods are more robust and effective. They can therefore not only help future studies of personalized disease diagnosis but also provide a better insight into clinical practice.
format Article
id doaj-art-8f4a33c5b64b4ffbb37fb27cccc7032f
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8f4a33c5b64b4ffbb37fb27cccc7032f2025-02-02T12:24:27ZengNature PortfolioScientific Reports2045-23222025-01-0115111710.1038/s41598-025-87438-1Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basisPeiyu Li0Shaowen Jing1Guo Tian2Jing Jiang3Network and Informatization Office, Henan University of Science and TechnologyNetwork and Informatization Office, Henan University of Science and TechnologyNetwork and Informatization Office, Henan University of Science and TechnologySchool of Mathematics and Statistics, Henan University of Science and TechnologyAbstract Complex diseases may not always progress in a gradual manner. In the early stages of complex diseases, obvious symptoms are usually not observable, but there is a commonality: there is a brief state of predisease between the progression from normal state to disease state, which usually includes three stages: normal state, critical state of predisease, and disease state. Identifying this critical state, especially with a single sample from an individual, remains a difficult task. In this study, we applied three methods, i.e., single-sample Jensen–Shannon Divergence (sJSD), network information gain (NIG), and temporal network flow entropy (TNFE) method, to a simulated dataset and type 2 diabetes (GSE13268 and GSE13269). Three different methods were utilized to create indexes, including the Inconsistency Index (ICI), NIG, and TNFE, to measure the overall disruption caused by individual samples compared to a set of reference samples. Changes in these indexes were used to identify critical states during the progression of the disease. Results from the numerical simulations show the effectiveness of the three methods. All the methods can detect two critical states based on a single sample, which are respectively at 8 weeks and 16 weeks for GSE13268 and at 4 weeks and 16 weeks for GSE13269, indicating the critical states before deterioration can be detected and the dynamic network biomarkers (DNBs) can be identified successfully. But there are differences in the sensitivity of predictive indicators based on the three methods. The identified dynamic network biomarkers are also significantly different. In addition, the computational principles of the three methods are compared. The proposed three methods can effectively detect the critical state and identify the DNB, solely based on a single sample. The three methods are data-driven and model-free on an individual basis. sJSD method is more sensitive to the critical state, while NIG and TNFE methods are more robust and effective. They can therefore not only help future studies of personalized disease diagnosis but also provide a better insight into clinical practice.https://doi.org/10.1038/s41598-025-87438-1Critical stateDynamic network biomarkerSingle-sample Jensen–Shannon Divergence (sJSD)Network information gain (NIG)Temporal network flow entropy (TNFE)
spellingShingle Peiyu Li
Shaowen Jing
Guo Tian
Jing Jiang
Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis
Scientific Reports
Critical state
Dynamic network biomarker
Single-sample Jensen–Shannon Divergence (sJSD)
Network information gain (NIG)
Temporal network flow entropy (TNFE)
title Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis
title_full Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis
title_fullStr Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis
title_full_unstemmed Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis
title_short Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis
title_sort revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis
topic Critical state
Dynamic network biomarker
Single-sample Jensen–Shannon Divergence (sJSD)
Network information gain (NIG)
Temporal network flow entropy (TNFE)
url https://doi.org/10.1038/s41598-025-87438-1
work_keys_str_mv AT peiyuli revealingthecriticalstateandidentifyingindividualizeddynamicnetworkbiomarkerfortype2diabetesthroughadvancedanalysismethodsonindividualbasis
AT shaowenjing revealingthecriticalstateandidentifyingindividualizeddynamicnetworkbiomarkerfortype2diabetesthroughadvancedanalysismethodsonindividualbasis
AT guotian revealingthecriticalstateandidentifyingindividualizeddynamicnetworkbiomarkerfortype2diabetesthroughadvancedanalysismethodsonindividualbasis
AT jingjiang revealingthecriticalstateandidentifyingindividualizeddynamicnetworkbiomarkerfortype2diabetesthroughadvancedanalysismethodsonindividualbasis